CL2007001456A1 - Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria. - Google Patents

Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria.

Info

Publication number
CL2007001456A1
CL2007001456A1 CL200701456A CL2007001456A CL2007001456A1 CL 2007001456 A1 CL2007001456 A1 CL 2007001456A1 CL 200701456 A CL200701456 A CL 200701456A CL 2007001456 A CL2007001456 A CL 2007001456A CL 2007001456 A1 CL2007001456 A1 CL 2007001456A1
Authority
CL
Chile
Prior art keywords
hemocromatosis
difenyl
triazols
hereditary
treatment
Prior art date
Application number
CL200701456A
Other languages
English (en)
Inventor
Hanspeter Rojkjaer Lisa Nick
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38859061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007001456(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2007001456A1 publication Critical patent/CL2007001456A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200701456A 2006-05-23 2007-05-22 Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria. CL2007001456A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74797406P 2006-05-23 2006-05-23
US80304906P 2006-05-24 2006-05-24
US83565806P 2006-08-04 2006-08-04

Publications (1)

Publication Number Publication Date
CL2007001456A1 true CL2007001456A1 (es) 2008-05-16

Family

ID=38859061

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200701456A CL2007001456A1 (es) 2006-05-23 2007-05-22 Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria.

Country Status (21)

Country Link
US (2) US20110105575A1 (es)
EP (2) EP2026801B1 (es)
JP (1) JP2009538329A (es)
KR (1) KR20080112407A (es)
AU (1) AU2007269536B2 (es)
BR (1) BRPI0712020A2 (es)
CA (1) CA2650433A1 (es)
CL (1) CL2007001456A1 (es)
DK (1) DK2026801T3 (es)
ES (1) ES2440806T3 (es)
HR (1) HRP20140096T1 (es)
IL (1) IL194659A0 (es)
MA (1) MA30432B1 (es)
MX (1) MX2008014837A (es)
NO (1) NO20084999L (es)
NZ (1) NZ572155A (es)
PL (1) PL2026801T3 (es)
PT (1) PT2026801E (es)
TN (1) TNSN08479A1 (es)
TW (1) TW200808745A (es)
WO (1) WO2008005624A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10694962B2 (en) 2011-06-13 2020-06-30 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2012174157A1 (en) * 2011-06-13 2012-12-20 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2024011188A1 (en) * 2022-07-07 2024-01-11 Protagonist Therapeutics, Inc. Combination therapy for treatment of iron overload diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW533205B (en) 1996-06-25 2003-05-21 Novartis Ag Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition
GB0408078D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2007269536B2 (en) 2011-06-30
CA2650433A1 (en) 2008-01-10
HRP20140096T1 (hr) 2014-02-28
MX2008014837A (es) 2008-12-01
PT2026801E (pt) 2014-02-06
EP2026801A2 (en) 2009-02-25
EP2255805A1 (en) 2010-12-01
US20110294861A1 (en) 2011-12-01
NZ572155A (en) 2011-11-25
EP2026801B1 (en) 2013-11-06
JP2009538329A (ja) 2009-11-05
WO2008005624A3 (en) 2008-03-13
NO20084999L (no) 2008-12-23
BRPI0712020A2 (pt) 2011-12-27
TW200808745A (en) 2008-02-16
DK2026801T3 (da) 2014-01-27
IL194659A0 (en) 2009-08-03
US20110105575A1 (en) 2011-05-05
MA30432B1 (fr) 2009-05-04
PL2026801T3 (pl) 2014-04-30
TNSN08479A1 (en) 2010-04-14
ES2440806T3 (es) 2014-01-30
AU2007269536A1 (en) 2008-01-10
WO2008005624A2 (en) 2008-01-10
KR20080112407A (ko) 2008-12-24

Similar Documents

Publication Publication Date Title
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2007003202A1 (es) Compuestos derivados de espiroindolinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de proliferacion celular.
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
CL2007003138A1 (es) Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
WO2008097561A8 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
BRPI0615163A2 (pt) composto, composição farmacêutica, uso do composto, e, métodos de tratamento de distúrbios mediados por mglur5 e para inibição da ativação de receptores de mglur5
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
CL2007001630A1 (es) Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
DK1801108T3 (da) Morpholinforbindelser til behandling af inflammationer.
CL2007002479A1 (es) Compuestos derivados de pirazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos tromboembolicos.
CL2007002951A1 (es) Uso de compuestos derivados de espiroheterociclicos en el tratamiento de hipercolesterolemia, hiperplasia benigna de prostata, pruritis, cancer.
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
BRPI0818170A2 (pt) 5-cianotienopiridinas para o tratamento de tumores.
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
DK1879581T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet
CL2007003847A1 (es) Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer.
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
BRPI0614480A2 (pt) composto, composição farmacêutica, uso do composto, e, métodos para tratamento de distúrbios mediados por mglur5 e para inibição da ativação de receptores de mglur5
CL2007001456A1 (es) Uso de compuestos derivados de 3,5-difenil 1,2,4-triazoles para el tratamiento de hemocromatosis hereditaria.